Skip to site content

Indian Health Service The Federal Health Program for American Indians and Alaska Natives

NPTC
National Pharmacy & Therapeutics Committee

IHS National Core Formulary

The IHS National Core Formulary is not an inclusive formulary, but should be considered a baseline to build upon. These agents were reviewed clinically and were considered as standard of care medications for frequently encountered disease states within the Indian Health System. Agents listed on the IHS National Core Formulary should be available on your local formulary.

NPTC Formulary Review Request Form
The NPTC seeks input from the field concerning potential topics for consideration. If you would like the NPTC to review a particular drug or drug class, please fill out the NPTC Formulary Review Request Form and submit to IHSNPTC1@ihs.gov.

Updated March 2015 National Core Formulary PDF Version [PDF - 123 KB]

Special Notes:
- To search by keyword through this page for a specific drug product, press "Control F".
- * Items in RED in the table below, indicate a closed class item. Facilties should not have any other formulary items from these classes.
- ** Items in Gray have been removed from the NCF
Also see, AHFS Classification Table and VA Class Table.

National Core Formulary

GenericReferencesGuidelinesAHFS ClassificationVA Class
5-HT agonist (Triptan) any product 28:32.28 CN105
Acetaminophen 28:08.92 CN103
Albuterol (Proventil HFA®) Branded product 12:12.08 RE102
Albuterol nebulized solution 12:12.08 RE102
Alendronate Medication guide [PDF] Exit Disclaimer: You Are Leaving www.ihs.gov 92:24.00 HS900
Allopurinol 84:08.00 MS400
Amitriptyline 28:14.04 CN601
Amlodipine 24:28.08 CV200
Anastrozole 10:00.00 AN500
Angiotensin Receptor Blocker Removed April 2012 24:32.08 CV805
Aspirin 28:08.04.24 CN103
Atenolol 24:24.00 CV100
Atorvastatin calcium ONLY 40mg to 80mg doses (high intensity statin to lower ldl-c > 50%) 24:06.08 CV350
Atypical Antipsychotic any product 28:16 CN700
Buproprion Medication guide [PDF] Exit Disclaimer: You Are Leaving www.ihs.gov 28:16.04 AN200
Calcium any formulation 40:12 TN420
Carbamazepine 28:12.92 CN400
Carvedilol (immediate release formulation only) 24:24.00 CV100
Chlorthalidone 40:28.24 CV701
Clindamycin topical any product 84:04.04 DE752
Clonazepam Medication guide [PDF] Exit Disclaimer: You Are Leaving www.ihs.gov 28:16.04 CN400
Clopidogrel bisulfate Medication guide [PDF] Exit Disclaimer: You Are Leaving www.ihs.gov 20:12.18 BL117
Combination (70/30) insulin, Novolin Branded product 68:20.08 HS501
Combination insulin, Novolog (70/30) mix Branded product 68:20.08 HS501
Copper Intrauterine Device, (Paragard) Branded product; CFU for use by a skilled and privileged provider 68:12 HS200
Corticosteroid topical (low potency) any product 84:06.00 DE200
Corticosteroid topical (Intermediate potency) any product 84:06.00 DE200
Dedicated Emergency Contraceptive Removed Sept 2013; any product 68:12 HS200
Depo-Medroxyprogesterone injection 68:32 HS800
Dextroamphetamine and Amphetamine (immediate release) Pediatric use only 28:20.04 CN801
Dextroamphetamine and Amphetamine (long-acting) Pediatric use only 28:20.04 CN801
Diclofenac any formulation 28:08.04.92 MS102
Digoxin 24:04.08 CV049
Diltiazem 24:28.92 CV200
Divalproex 28:12.92 CN400
Donepezil 5mg and 10mg strengths 12:04 CN900
Doxazosin 24:20.00 CV150
Emtricitabine/Tenofovir (Truvada®) Post-Exposure Prophylaxis 08:18.08 AM800
Estradiol tablets 68.16.04 HS000
Ethambutol 08:16.04 AM500
Ethinyl estradiol/etonorgestrel vaginal ring (NuvaRingÒ) 68:12 GU400
Ethinyl estradiol/norelgestromin transdermal (Ortho-EvraÒ) 68:12 GU400
Etonogestril implant (NexplanonÒ) Branded product; CFU for use by a skilled and priveleged provider 68:12 HS200
Fibric Acid Derivative any product 24:06.06 CV350
Finasteride 92:00.00 HS900
Fluoxetine 28:12.08 CN609
Fluticasone/Salmeterol (Advair®) Removed October 2012; Branded product; Medication guide, communication plan [PDF] Exit Disclaimer: You Are Leaving www.ihs.gov 12:12.08.12 & 68.0 RE101/RE102
Furosemide 40:28.20 CV702
Gabapentin Medication guide [PDF] Exit Disclaimer: You Are Leaving www.ihs.gov 28:12.92 CN400
Gemfibrozil Removed February 2014; replaced with "Fibric Acid Derivative - any product" 24:06.06 CV350
Glipizide 68:20.20 HS502
Glucagon For outpatient use 68:22.12 HS503
Glyburide 68:20.20 HS502
H1 Antagonist-2nd generation, long-acting any product 04:08.00 AH000
Hydrochlorothiazide 40:28.20 CV701
Hydroxychloroquine 08:30.08  AP101
Ibuprofen 28:08.04.92 MS102
Imipramine Removed May 2014 28:14.04 CN601
Indomethacin 28:08.04.92 MS102
Intermediate-acting (NPH) insulin, Novolin Branded product 68:20.08 HS501
Intranasal corticosteroid any product 52:08.08 NT200
Ipratropium MDI 12:08.08 RE105
Isoniazid 08:16.04 AM500
Isosorbide dinitrate Removed August 2013 24:12.08 CV250
Isosorbide mononitrate 24:12.08 CV250
Lactulose 40:10 GA202
Lamotrigine 28:12.92 CN400
Laxative, bulk-forming any product 56:12 GA201
Laxative, osmotic any product 56:12 GA202
Laxative, stimulant any product 56:12 GA204
Letrozole 10:00.00 AN900
Levetiracetam 28:12.92 CN400
Levonorgestrel (Plan B One-Step®) Branded product 68:12 HS200
Levonorgestrel-releasing intrauterine device (MirenaÒ) Branded product; CFU for use by a skilled and privileged provider 68:12 HS200
Levothyroxine 68:36.04 HS851
Lisinopril 24:32.04 CV800
Lithium 28:28.00 CN750
Long-acting insulin, Insulin Detemir (Levemir®) Branded product 68:20.08 HS501
Lopinavir/Ritonavir (Kaletra®) Removed August 2013; Post-exposure prophylaxis; Medication guide [PDF] Exit Disclaimer: You Are Leaving www.ihs.gov 08:18.08 AM800
Lorazepam 28:12.08 CN400
Losartan 24:32:08 CV805
Lovastatin Removed April 2012 24:06.08 CV350
Low-molecular weight heparin any product 20:12.04 BL110
Meloxicam 28:08.04.92 MS102
Metformin 68:20.04 HS502
Methotrexate 10:00.00 AN300
Methylphenidate (immediate release) Pediatric use only 28:20.92 CN802
Methylphenidate (long-acting) Pediatric use only 28:20.92 CN802
Metoprolol 24:24.00 CV100
Mometasone (Asmanex®) Branded product 68:04.00 RE101
Mometasone/Formoterol (Dulera®) Branded product 12:12.08.12 & 68.0 RE101/RE102
Monophasic Oral Contraceptive Pill 30-35mcg EE (medium) any product 68:12 HS200
Monophasic Oral Contraceptive Pill (OCP) 20mcg EE (low) any product 68:12 HS200
Montelukast 48:10.24 RE109
Naloxone 28:10 CN102
Naltrexone 28:10 CN102
Naproxen 28:08.04.92 MS102
Niacin extended release (Niaspan®) 24:06.92.5
VT103
Nicotine Replacement Therapy any product 12:00 IM900
Nifedipine (controlled or extended release) Removed August 2014 24:28.08 CV200
Nitroglycerin 0.4 milligrams, sublingual 24:12.08 CV250
Nitroglycerin patch 24:12.08 CV250
Nortriptyline 26:16.04 CN601
Omeprazole (enteric coated) Removed February 2014; replaced with "Proton-Pump Inhibitors - any product",Closed class status removed July 2012 56:28.36 GA900
Ophthalmic Prostaglandin Analogue any product 52:36.00 OP109
Oxybutynin 86:12.00 GU201
Phenytoin 28:12.12 CN400
Pioglitazone Removed February 2010; Medication guide [PDF] Exit Disclaimer: You Are Leaving www.ihs.gov 68:20.28 HS502
Pravastatin 24:06.08 CV350
Prazosin 24:20.00 CV150
Prednisone 68:04.00 HS051
Premarin® Vaginal Cream Branded product 68:16.04 HS000
Progestin (oral) any product 68:32 HS800
Progestin Only Oral Contraceptive Pill any product 68:32 HS800
Propranolol 24:24.00 CV100
Proton-Pump Inhibitor any product 56:28.36 GA900
Pyrazinamide 08:16.04 AM500
Raltegravir (Isentress®) Post-Exposure Prophylaxis 08:18.08.12 AM800
Ranitidine 56:28.12 GA301
Rapid-acting (regular) insulin, Novolin Branded product 68:20.08 HS501
Rifampin 08:16.04 AM500
Rifapentine 08:16.04 AM500
Rosuvastatin 20mg Removed April 2012 24:06.08 CV350
Salmeterol (Serevent®) Removed September 2011; Medication guide, communication plan [PDF] Exit Disclaimer: You Are Leaving www.ihs.gov 12:12.08 RE102
Salsalate 28:08.04.24 MS102
Sertraline 28:16.04 CN609
Sevelamer (Renvela®) For patients on dialysis that cannot use calcium based phosphate binders due to hypercalcemia; branded product 92:00.00 AD900
Simvastatin 24:06.08 CV350
Spironolactone 24:32.20 CV704
Sulfasalazine 08:12.20 GA900
Sulindac Removed May 2014 28:08.04 MS102
Tamoxifen 10:00.00 AN500
Tamsulosin 92:00.00 CV150
Terazosin Removed January 2012 24:20.00 CV150
Tetanus, Diptheria, and acellular Pertussis (Tdap) 80:08.00 IM100
Tiotropium (Spiriva®) Branded product 12:08.08 RE105
Topiramate 28:12.92 CN400
Trazodone 28:16.04 CN609
Tretinoin Topical any product 86:16.00 DE752
Triphasic Oral Contraceptive Pill any product 68:12 HS200
Trospium 86:12.00 GU201
Ultra-rapid-acting insulin, Novolog Branded product 68:20.08 HS501
Vaccines all ACIP recommended vaccines for routine use in accordance with ACIP guidelines 80:12.00 IM100
Venlafaxine 28:16.04 CN609
Verapamil Removed August 2014 24:28.92 CV200
Vitamin D any product 88:16 VT500
Warfarin 20:12.04 BL110
Back To Top
CPU: 1240ms Clock: 1s